Imaging of Cell Proliferation: Status and Prospects
Open accessThe DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
Increased cellular proliferation is an integral part of the cancer phenotype. Several in vitro assays have been developed to measure the rate of tumor growth, but these require biopsies, which are particularly difficult to obtain over time and in different areas of the body in patients with multiple metastatic lesions. Most of the effort to develop imaging methods to noninvasively measure the rate of tumor cell proliferation has focused on the use of PET in conjunction with tracers for the thymidine salvage pathway of DNA synthesis, because thymidine contains the only pyrimidine or purine base that is unique to DNA. Imaging with 11C-thymidine has been tested for detecting tumors and tracking their response to therapy in animals and patients. Its major limitations are the short half-life of 11C and the rapid catabolism of thymidine after injection. These limitations led to the development of analogs that are resistant to degradation and can be labeled with radionuclides more conducive to routine clinical use, such as 18F. At this point, the thymidine analogs that have been studied the most are 3'-deoxy-3'-fluorothymidine (FLT) and 1-(2'-deoxy-2'-fluoro-1-beta-d-arabinofuranosyl)-thymine (FMAU). Both are resistant to degradation and track the DNA synthesis pathway. FLT is phosphorylated by thymidine kinase 1, thus being retained in proliferating cells. It is incorporated by the normal proliferating marrow and is glucuronidated in the liver. FMAU can be incorporated into DNA after phosphorylation but shows less marrow uptake. It shows high uptake in the normal heart, kidneys, and liver, in part because of the role of mitochondrial thymidine kinase 2. Early clinical data for 18F-FLT demonstrated that its uptake correlates well with in vitro measures of proliferation. Although 18F-FLT can be used to detect tumors, its tumor-to-normal tissue contrast is generally lower than that of 18F-FDG in most cancers outside the brain. The most promising use for thymidine and its analogs is in monitoring tumor treatment response, as demonstrated in animal studies and pilot human trials. Further work is needed to determine the optimal tracer(s) and timing of imaging after treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Ki-67 protein: From the known and the unknown
Scholzen, T., & Gerdes, J. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200003)182:3<311::aid-jcp1>3.0.co;2-9 · Cited by 4,646
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
Massoud, T. F., & Gambhir, S. S. (2003) · Genes & Development · doi:10.1101/gad.1047403 · Cited by 2,216
Partial-Volume Effect in PET Tumor Imaging
Soret, M., Bacharach, S. L., & Buvat, I. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.035774 · Cited by 1,549
Imaging proliferation in vivo with [F-18]FLT and positron emission tomography
Shields, A. F., Grierson, J. R., Dohmen, B. M., Machulla, H.-J., Stayanoff, J. C., Lawhorn-Crews, J. M., Obradovich, J. E., Muzik, O., & Mangner, T. J. (1998) · Nature Medicine · doi:10.1038/3337 · Cited by 1,204
Self-citationThymidine metabolism and cell kinetics
Cleaver, J. E. (1967) · Medical Entomology and Zoology · Cited by 510
Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG.
Buck, A. K., Halter, G., Schirrmeister, H., Kotzerke, J., Wurziger, I., Glatting, G., Mattfeldt, T., Neumaier, B., Reske, S. N., & Hetzel, M. (2003) · PubMed · Cited by 439
Regulation of human thymidine kinase during the cell cycle.
Sherley, J. L., & Kelly, T. J. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68484-4 · Cited by 438
Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
Chen, W., Cloughesy, T. F., Kamdar, N. V., Satyamurthy, N., Bergsneider, M., Liau, L. M., Mischel, P. S., Czernin, J., Phelps, M. E., & Silverman, D. H. S. (2005) · PubMed · Cited by 437
Prognostic value of proliferation in invasive breast cancer: a review: Table 1
van Diest, P. J., van der Wall, E., & Baak, J. P. A. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.010777 · Cited by 385
Higashi, K., Clavo, A. C., & Wahl, R. L. (1993) · PubMed · Cited by 310
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?
Colozza, M., Azambuja, E., Cardoso, F., Sotiriou, C., Larsimont, D., & Piccart, M. J. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi352 · Cited by 307
Vesselle, H. J., Grierson, J. R., Muzi, M., Pugsley, J. M., Schmidt, R. A., Rabinowitz, P., Peterson, L. M., Vallières, E., & Wood, D. E. (2002) · PubMed · Cited by 300
Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.
Shi, K., Wen, X., Gurfinkel, M., Charnsangavej, C., Wallace, S., Sevick-Muraca, E. M., & Li, C. (2003) · PubMed · Cited by 293
Kenny, L., Coombes, R. C., Vigushin, D. M., Al-Nahhas, A., Shousha, S., & Aboagye, E. O. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0379-4 · Cited by 275
Barthel, H., Cleij, M. C., Collingridge, D. R., Hutchinson, O. C., Osman, S., He, Q., Luthra, S. K., Brady, F., Price, P., & Aboagye, E. O. (2003) · PubMed · Cited by 271
Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model.
van Waarde, A., Cobben, D., Suurmeijer, A. J. H., Maas, B., Vaalburg, W., de Vries, E. F. J., Jager, P. L., Hoekstra, H. J., & Elsinga, P. H. (2004) · PubMed · Cited by 263
Jacobs, A. H., Thomas, A., Kracht, L., Li, H., Dittmar, C., Garlip, G., Galldiks, N., Klein, J. C., Sobesky, J., Hilker, R., et al. (2005) · PubMed · Cited by 245
Transport of nucleoside drugs in animal cells
Paterson, A. R. P., Kolassa, N., & Cass, C. E. (1981) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(81)90096-6 · Cited by 238
Yoshimoto, M., Waki, A., Yonekura, Y., Sadato, N., Murata, T., Omata, N., Takahashi, N., Welch, M. J., & Fujibayashi, Y. (2001) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00195-5 · Cited by 236
Mitochondria: a target for cancer therapy
Armstrong, J. S. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706556 · Cited by 232
Pio, B. S., Park, C. K., Pietras, R., Hsueh, W.-A., Satyamurthy, N., Pegram, M. D., Czernin, J., Phelps, M. E., & Silverman, D. H. S. (2006) · Molecular Imaging and Biology · doi:10.1007/s11307-005-0029-9 · Cited by 223
Carbon-11-thymidine and FDG to measure therapy response.
Shields, A. F., Mankoff, D. A., Link, J. M., Graham, M. M., Eary, J. F., Kozawa, S. M., Zheng, M., Lewellen, B., Lewellen, T. K., Grierson, J. R., et al. (1998) · PubMed · Cited by 216
Self-citationGrierson, J. R., & Shields, A. F. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(99)00104-3 · Cited by 214
Self-citationBuck, A. K., Schirrmeister, H., Hetzel, M., Heide, M. V. D., Halter, G., Glatting, G., Mattfeldt, T., Liewald, F., Reske, S. N., & Neumaier, B. (2002) · PubMed · Cited by 213
[18F]3′-deoxy-3′-fluorothymidine PET for the diagnosis and grading of brain tumors
Choi, S. J., Kim, J. S., Kim, J. H., Oh, S. J., Lee, J. G., Kim, C. J., Ra, Y. S., Yeo, J. S., Ryu, J. S., & Moon, D. H. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1742-3 · Cited by 189
Molecular Imaging of Proliferation in Malignant Lymphoma
Buck, A. K., Bommer, M., Stilgenbauer, S., Juweid, M., Glatting, G., Schirrmeister, H., Mattfeldt, T., Tepsic, D., Bunjes, D., Mottaghy, F. M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1955 · Cited by 185
Yap, C. S., Czernin, J., Fishbein, M. C., Cameron, R. B., Schiepers, C., Phelps, M. E., & Weber, W. A. (2006) · Chest · doi:10.1378/chest.129.2.393 · Cited by 166
PET imaging of cellular proliferation
Mankoff, D. A., Shields, A. F., & Krohn, K. A. (2005) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2004.09.005 · Cited by 161
Self-citationTroost, E. G. C., Vogel, W. V., Merkx, M. A. W., Slootweg, P. J., Marres, H. A. M., Peeters, W. J. M., Bussink, J., van der Kogel, A. J., Oyen, W. J. G., & Kaanders, J. H. A. M. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.037473 · Cited by 161
Arulampalam, T., Luthra, S. K., Taylor, I., Francis, D., Visvikis, D., Ell, P. J., Townsend, C., & Costa, D. C. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1187-0 · Cited by 153
Leyton, J., Latigo, J. R., Perumal, M., Dhaliwal, H., He, Q., & Aboagye, E. O. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4008 · Cited by 153
Herrmann, K., Wieder, H. A., Buck, A. K., Schöffel, M., Krause, B., Fend, F., Schuster, T., Büschenfelde, C. M. Z., Wester, H., Duyster, J., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-3025 · Cited by 153
Yamamoto, Y., Nishiyama, Y., Ishikawa, S., Nakano, J., Chang, S. S., Bandoh, S., Kanaji, N., Haba, R., Kushida, Y., & Ohkawa, M. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0449-7 · Cited by 147
Papo, N., Seger, D., Makovitzki, A., Kalchenko, V., Eshhar, Z., Degani, H., & Shai, Y. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4569 · Cited by 147
FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors.
Higashi, T., Tamaki, N., Torizuka, T., Nakamoto, Y., Sakahara, H., Kimura, T., Honda, T., Inokuma, T., Katsushima, S., Ohshio, G., et al. (1998) · PubMed · Cited by 147
Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer.
van Westreenen, H. L., Cobben, D., Jager, P. L., van Dullemen, H. M., Wesseling, J., Elsinga, P. H., & Plukker, J. T. M. (2005) · PubMed · Cited by 144
McKnight, T. R., Lamborn, K. R., Love, T. D., Berger, M. S., Chang, S. M., Dillon, W. P., Bollen, A. W., & Nelson, S. J. (2007) · Journal of neurosurgery · doi:10.3171/jns.2007.106.4.660 · Cited by 139
Imaging DNA synthesis with [18F]FMAU and positron emission tomography in patients with cancer
Sun, H., Sloan, A. E., Mangner, T. J., Vaishampayan, U. N., Muzik, O., Collins, J. M., Douglas, K. A., & Shields, A. F. (2004) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1713-8 · Cited by 123
Self-citationEarly changes in [ 18 F]FLT uptake after chemotherapy: an experimental study
Dittmann, H., Dohmen, B. M., Kehlbach, R., Bartusek, G., Pritzkow, M., Sarbia, M., & Bares, R. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0925-z · Cited by 120
Kinetic modeling of 3'-deoxy-3'-fluorothymidine in somatic tumors: mathematical studies.
Muzi, M., Mankoff, D. A., Grierson, J. R., Wells, J. M., Vesselle, H. J., & Krohn, K. A. (2005) · PubMed · Cited by 116
Sato, N., Suzuki, M., Kuwata, N., Kuroda, K., Wada, T., Beppu, T., Sera, K., Sasaki, T., & Ogawa, A. (1999) · Neurosurgical Review · doi:10.1007/s101430050018 · Cited by 111
Thymidine concentrations in serum and urine of different animal species and man
Nottebrock, H., & Then, R. L. (1977) · Biochemical Pharmacology · doi:10.1016/0006-2952(77)90271-4 · Cited by 108
In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer
Breeuwsma, A. J., Pruim, J., Jongen, M. M., Suurmeijer, A. J. H., Vaalburg, W., Nijman, R. J. M., & de Jong, I. J. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1741-4 · Cited by 107
Martiat, P., Ferrant, A., Labar, D., Cogneau, M., Bol, A., Cogneau, M., Michaux, J., & SOKAL, G. (1988) · PubMed · Cited by 106
Radiolabeled choline as a proliferation marker: Comparison with radiolabeled acetate
Yoshimoto, M., Waki, A., Obata, A., Furukawa, T., Yonekura, Y., & Fujibayashi, Y. (2004) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2004.05.002 · Cited by 105
Waldherr, C., Mellinghoff, I. K., Tran, C., Halpern, B. S., Rozengurt, N., Safaei, A., Weber, W., Stout, D., Satyamurthy, N., Barrio, J. R., et al. (2005) · PubMed · Cited by 104
Chapter 19 Analysis of Nucleotide Pools in Animal Cells
Hauschka, P. V. (1974) · Methods in cell biology · doi:10.1016/s0091-679x(08)61787-2 · Cited by 103
Clinical relevance of imaging proliferative activity in lung nodules
Buck, A. K., Hetzel, M., Schirrmeister, H., Halter, G., Möller, P., Kratochwil, C., Wahl, A., Glatting, G., Mottaghy, F. M., Mattfeldt, T., et al. (2004) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1706-7 · Cited by 98
Nuclear medicine imaging to predict response to radiotherapy: a review
de Wiele, C. V., Lahorte, C., Oyen, W. J. G., Boerman, O. C., Goethals, I., Slegers, G., & Dierckx, R. A. J. O. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)04122-6 · Cited by 96
SUGIYAMA, M., Sakahara, H., Sato, K., Harada, N., Fukumoto, D., Kakiuchi, T., Hirano, T., Kohno, E., & Tsukada, H. (2004) · PubMed · Cited by 96
Characterization of brain tumors by MRS, DWI and Ki-67 labeling index
永井, 暁., Meli, F. J., Romero, C., Yánez, M. L. C. P., Martinez, A. R., Lambré, H., Taratuto, A. L., & Sevlever, G. E. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-004-3342-2 · Cited by 92
Contribution of labeled carbon dioxide to PET imaging of carbon-11-labeled compounds.
Shields, A. F., Graham, M. M., Kozawa, S. M., Kozell, L. B., Link, J. M., Swenson, E. R., Spence, A. M., Bassingthwaighte, J. B., & Krohn, K. A. (1992) · PubMed · Cited by 83
Self-citationProduction of [2-11C]thymidine for quantification of cellular proliferation with PET
Borght, T. V., Labar, D., Pauwels, S. A., & Lambotte, L. (1991) · International Journal of Radiation Applications and Instrumentation Part A Applied Radiation and Isotopes · doi:10.1016/0883-2889(91)90131-j · Cited by 81
Comparison of methodologies for the in vivo assessment of 18 FLT utilisation in colorectal cancer
Luthra, S. K., Taylor, I., Ell, P. J., Visvikis, D., Francis, D., Mulligan, R. S., Costa, D. C., & Croasdale, I. R. (2004) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1339-2 · Cited by 79
Measuring response to chemotherapy in locally advanced breast cancer: methodological considerations
Krak, N. C., Lammertsma, A. A., & Hoekstra, O. S. (2004) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1532-y · Cited by 79
Leyton, J., Alao, J. P., Costa, M. D., Stavropoulou, A. V., Latigo, J. R., Perumal, M., Pillai, R. G., He, Q., Atadja, P. W., Lam, E. W. ‐., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3962 · Cited by 72
Rat studies comparing 11C-FMAU, 18F-FLT, and 76Br-BFU as proliferation markers.
Lu, L., Samuelsson, L. M., Bergström, M., Sato, K., Fasth, K., & Långström, B. (2002) · PubMed · Cited by 70
CHUNG, J.-K., Lee, Y. J., KIM, S. K., Jeong, J. M., Lee, D. S., & Lee, M. C. (2003) · Nuclear Medicine Communications · doi:10.1097/00006231-200401000-00003 · Cited by 69
Wang, J., & Eriksson, S. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.6.1555 · Cited by 66
Cobben, D., Elsinga, P. H., Hoekstra, H. J., Suurmeijer, A. J. H., Vaalburg, W., Maas, B., Jager, P. L., & Groen, H. J. M. (2004) · PubMed · Cited by 64
Miyazawa, H., Arai, T., Iio, M., & Hara, T. (1993) · PubMed · Cited by 64
Watanabe, K., Nomori, H., Ohtsuka, T., Naruke, T., Ebihara, A., Orikasa, H., Yamazaki, K., Uno, K., Kobayashi, T., & Goya, T. (2006) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyl043 · Cited by 63
Imaging DNA synthesis in vivo with 18F-FMAU and PET.
Sun, H., Mangner, T. J., Collins, J. M., Muzik, O., Douglas, K. A., & Shields, A. F. (2005) · Journal of Nuclear Medicine · Cited by 62
Self-citationBrooks, D. J., Lammertsma, A. A., Beaney, R. P., Leenders, K. L., Buckingham, P. D., Marshall, J., & Jones, T. (1984) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1984.65 · Cited by 60
Haberkorn, U., Bellemann, M. E., Altmann, A., Gerlach, L., Morr, I., Oberdorfer, F., Brix, G., Doll, J., Blatter, J., & KAICK, G. V. (1997) · PubMed · Cited by 51
Schiepers, C. W., Haustermans, K. M., Geboes, K., Filez, L., Bormans, G. M., & PENNINCKX, F. M. (1999) · Cancer · Cited by 46
de Wolde, H., Pruim, J., Mastik, M. F., Koudstaal, J., & Molenaar, W. M. (1997) · PubMed · Cited by 42
Synthesis and biological effects of 2'-fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil
Chou, T., Kong, X., Fanucchi, M., Cheng, Y., Takahashi, K., Watanabe, K. A., & Fox, J. J. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.9.1355 · Cited by 37
Halter, G., Buck, A. K., Schirrmeister, H., et al. (2004) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2003.09.003 · Cited by 36
Jager, P. L., Plaat, B. E. C., de Vries, E. G. E., Molenaar, W. M., Vaalburg, W., Piers, D. A., & Hoekstra, H. J. (2000) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 34
Noninvasive Fluorescent Imaging Reliably Estimates Biomass In Vivo
Diehn, F. E., Costouros, N. G., Miller, M. S., Feldman, A. L., Alexander, H. R., Li, K. C., & Libutti, S. K. (2002) · BioTechniques · doi:10.2144/02336st02 · Cited by 20
Wells, P., West, C., Jones, T., Harris, A. L., & Price, P. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2004.09.007 · Cited by 19
Al‐Saeedi, F. J., Smith, T., & Welch, A. (2007) · PubMed · Cited by 16
Cited by
Recent Advances of Optical Imaging in the Second Near‐Infrared Window
Kenry, Duan, Y., & Liu, B. (2018) · Advanced Materials · doi:10.1002/adma.201802394 · Cited by 810
Skeletal PET with18F-Fluoride: Applying New Technology to an Old Tracer
Grant, F. D., Fahey, F. H., Packard, A. B., Davis, R. T., Alavi, A., & Treves, S. T. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.037200 · Cited by 520
Physics of pure and non-pure positron emitters for PET: a review and a discussion
Conti, M., & Eriksson, L. (2016) · EJNMMI Physics · doi:10.1186/s40658-016-0144-5 · Cited by 393
Zaidi, H., & El Naqa, I. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1423-3 · Cited by 366
Murray, B. W., Guo, C., Piraino, J., Westwick, J. K., Zhang, C., Lamerdin, J., Dagostino, E., Knighton, D., Loi, C.-M., Zager, M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911863107 · Cited by 325
Metadata
- Authors
- Bading, J. R., & Shields, A. F.
- Venue
- Journal of Nuclear Medicine
- Publisher
- Society of Nuclear Medicine
- Published
- 2008-06
- Volume
- 49
- Issue
- Suppl 2
- Pages
- 64S-80S
- ISSN
- 0161-5505 (ISSN-L)
- 2159-662X
- OpenAlex
- W2105315565
- Cited by
- 320
- References
- 73
- FWCI
- 24.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.